secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2023-12-01T23:59:59+00:00
Accession:  0001654954-23-015069
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tenax Therapeutics shareholders approve reverse stock split authorization
-------------------------------------------------------------------------

- Reverse split ratio range 1:10 to 1:80, exact ratio set by board; authorized until Nov 30, 2024.
- For: 6,198,812; Against: 5,364,151; Abstain: 23,186; no broker non-votes.
- Adjournment proposal also approved (6,308,531 for, 5,052,193 against) but not used.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000165495423015069/0001654954-23-015069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000165495423015069/tenx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-015069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer